MicroRNA-552 expression in colorectal cancer and its clinicopathological significance

Background MicroRNA-552 (miR-552) has been reported to correlate with the development and progression of various cancers, including colorectal cancer (CRC). This study aimed to investigate miR-552 expression in cancer tissue samples compared to normal mucosal tissue and its role as a diagnostic or p...

Full description

Saved in:
Bibliographic Details
Main Authors: Joon Im (Author), Soo Kyung Nam (Author), Hye Seung Lee (Author)
Format: Book
Published: Korean Society of Pathologists & the Korean Society for Cytopathology, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c8c3253aae7d43ea829e20f4c4d98c3c
042 |a dc 
100 1 0 |a Joon Im  |e author 
700 1 0 |a Soo Kyung Nam  |e author 
700 1 0 |a Hye Seung Lee  |e author 
245 0 0 |a MicroRNA-552 expression in colorectal cancer and its clinicopathological significance 
260 |b Korean Society of Pathologists & the Korean Society for Cytopathology,   |c 2021-03-01T00:00:00Z. 
500 |a 2383-7837 
500 |a 2383-7845 
500 |a 10.4132/jptm.2021.01.17 
520 |a Background MicroRNA-552 (miR-552) has been reported to correlate with the development and progression of various cancers, including colorectal cancer (CRC). This study aimed to investigate miR-552 expression in cancer tissue samples compared to normal mucosal tissue and its role as a diagnostic or prognostic marker in CRC patients. Methods Normal mucosal tissues and primary cancer tissues from 80 surgically resected CRC specimens were used. Quantitative real-time polymerase chain reaction was performed for miR-552 and U6 small nuclear RNA to analyze miR-552 expression and its clinicopathological significance. Immunohistochemistry for p53 and phosphatase and tension homolog (PTEN) was performed to evaluate their association with miR-552 expression. Results miR-552 expression was significantly higher in primary cancer tissues compared to normal mucosal tissues (p<.001). The expression level of miR552 was inversely correlated with that of PTEN (p=.068) and p53 (p=.004). Survival analysis showed that high miR-552 expression was associated with worse prognosis but this was not statistically significant (p=.255). However, patients with CRC having high miR-552 expression and loss of PTEN expression had significantly worse prognosis than others (p=.029). Conclusions Our results suggest that high miR-552 expression might be a potential diagnostic biomarker for CRC, and its combined analysis with PTEN expression can possibly be used as a prognostic marker. 
546 |a EN 
546 |a KO 
690 |a mir-552 
690 |a colorectal neoplasms 
690 |a p53 
690 |a pten 
690 |a prognosis 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Journal of Pathology and Translational Medicine, Vol 55, Iss 2, Pp 125-131 (2021) 
787 0 |n http://www.jpatholtm.org/upload/pdf/jptm-2021-01-17.pdf 
787 0 |n https://doaj.org/toc/2383-7837 
787 0 |n https://doaj.org/toc/2383-7845 
856 4 1 |u https://doaj.org/article/c8c3253aae7d43ea829e20f4c4d98c3c  |z Connect to this object online.